Key result
Current laboratory testing in disseminated intravascular coagulation requires an emphasis on identifying the early phase of the disease and practicality to facilitate earlier therapeutic intervention.
Answers are grounded in this paper and cite their sources.
Highlights the need for practical laboratory tests that identify the early phase of DIC to improve clinical prognosis and facilitate therapeutic trials.
The lack of improvement in the clinical prognosis of disseminated intravascular coagulation (DIC) poses searching questions on the value of current laboratory testing in this area. There is little immediate chance of advancement unless new tests or new modes of analyzing currently available tests place an emphasis on identifying the early phase of DIC. An equal emphasis is also required on practicality to ensure that recommendations are applicable to the routine clinical setting. These two priorities need to be fulfilled to facilitate earlier therapeutic intervention in the clinical trials required for formal assessment of promising and emerging new molecules from successful animal studies. This article therefore discusses the advantages and disadvantages of available assays in DIC with these perspectives in mind. It also proposes a format to bring together the necessary elements required to make an impact on ultimately delivering clinical improvement in this critical area.
No takes yet. Share an insight, caveat, or question.
Cheng Hock Toh (2001) conducted a review in Disseminated intravascular coagulation (DIC). Laboratory testing was evaluated. Current laboratory testing in disseminated intravascular coagulation requires an emphasis on identifying the early phase of the disease and practicality to facilitate earlier therapeutic intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: